Remove 2011 Remove Healthcare Remove Pharmacology
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Active immunotherapy through vaccination has a far lower cost than mAb-based therapies, representing an important decrease of economic burden for healthcare systems at a global scale. Marija joined AC Immune SA in Lausanne in 2011 as a research scientist and subsequently became a team leader in vaccine discovery.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. Herbal medicines placed on the market since April 2011 must have either a traditional herbal registration (THR) or a Marketing Authorisation (MA). 2012/1916).

Marketing 103